Brand record

Patanjali Ayurved and Divya Pharmacy: what is on record

Last checked 10 October 2026

Patanjali. Status: Not banned; no national order against any product.

Nothing made by Patanjali Ayurved or Divya Pharmacy is banned nationally: on record are the 2024 Uttarakhand suspensions (cancelled by the state, reported), the Supreme Court case closed on 11 Aug 2025, Maharashtra's Jun 2026 advertising seizures, and one failed lab test, Arjuna Kwath.

Classification
No ban or recall found in official records
Decided by
No national regulator action on record
Reference
Uttarakhand order of 15 Apr 2024; IMA v Union of India, W.P.(C) 645/2022; Maharashtra FDA seizures of Jun 2026; Maharashtra FDA NSQ table of 9 Oct 2026
Latest action
6 November 2025
Last checked
10 October 2026

Patanjali Ayurved logo (PD-textlogo). Photo: Patanjali Logo.svg by Patanjali Ayurved (Public domain). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.

Primary government sourceTier 1: government primary source

Maharashtra FDA: not of standard quality (NSQ) alerts table

No national regulator action on record · Uttarakhand order of 15 Apr 2024; IMA v Union of India, W.P.(C) 645/2022; Maharashtra FDA seizures of Jun 2026; Maharashtra FDA NSQ table of 9 Oct 2026 · 9 October 2026

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.

Key facts

Event 1: Uttarakhand, 15 Apr 2024
Manufacturing licences of 14 Divya Pharmacy and Patanjali products suspended under Rule 159(1); the state cancelled the suspension on 1 Jul 2024 (reported)
Event 2: Supreme Court
IMA v Union of India, W.P.(C) 645/2022; contempt proceedings closed after apologies in Aug 2024; petition disposed of on 11 Aug 2025
Event 3: Maharashtra, Jun 2026
About Rs 51 lakh of Divya Pharmacy products seized under the DMR Act; Bombay High Court; no coercive action for now
Lab test
Divya Arjuna Kwath: microbial limit, in Maharashtra FDA's NSQ table
Abroad
No Patanjali entry on the US FDA import alerts read

No Patanjali or Divya Pharmacy product is banned nationally. Three events and one lab result are on record. On 15 Apr 2024 the Uttarakhand State Licensing Authority suspended the manufacturing licences of 14 products under Rule 159(1) for repeated misleading advertising; the state is reported to have cancelled that order on 1 Jul 2024.

The Supreme Court heard Indian Medical Association v Union of India (W.P.(C) 645/2022) over misleading advertisements. Contempt proceedings against Ramdev and Balkrishna were closed after apologies in Aug 2024, and the petition was disposed of on 11 Aug 2025. In Jun 2026 Maharashtra FDA seized about Rs 51 lakh of Divya Pharmacy products under the Drugs and Magic Remedies Act; Patanjali moved the Bombay High Court and the state said it would take no coercive action for the time being.

Maharashtra FDA's table of failed lab tests, as of 9 Oct 2026, lists one Divya Pharmacy product, Arjuna Kwath, for microbial limit. That is a finding on a tested sample, not on the brand.

What this means for you

Four different things

A licence suspension, a court case on advertising, a seizure under an advertising law and a failed lab test are not bans and are not the same event.

Go to the product

Each event names its products. The linked pages give them.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Common questions

Is any Patanjali product banned?

No product is banned nationally. See 'Is Patanjali banned in India?' for the dated timeline.

Official sources and primary records